Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...

Rapamycin, a natural compound, has shown anti-aging and health benefits in various researches. Consequently, the popularity and demand for rapamycin supplements have surged significantly in the ...

Researchers say study findings have important implications for our understanding of the pathogenesis of obesity and potential therapeutic applications.

Most obese patients grow resistant to satiety signals from the hormone leptin. A new study shows that leptin sensitivity can be restored in mice, leading to weight loss.

Scientists have identified a potential new benefit of a well-known drug: extending lifespan by improving mitophagy, the ...

Rapamycin is a naturally occurring compound primarily used to prevent organ rejection in transplant patients. It’s also considered a promising anti-aging drug among longevity seekers.

But out of all the supplements and drugs he takes for 'living healthy forever', one key medicine that Bryan and other ...

Jeffrey Friedman and Kristina Hedbacker, research associate, were first authors, as was Bowen Tan (pictured below). (Credit: ...

Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology ...

Encapsulated rapamycin is expected to prevent disease progression by inhibiting mTOR, a protein kinase that has been shown to be overexpressed in FAP polyps. The Food and Drug Administration (FDA ...

Quoin Pharmaceuticals (QNRX) announced it has filed U.S. and International patent applications for novel topical rapamycin formulations as ...

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.